PFx Biotech vs Triomics
PFx Biotech vs Triomics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: PFx Biotech is on 51/100 and Triomics on 53/100.
Where each one leads
PFx Biotech
- agent readiness: 44/100 against 30/100
Triomics
- domain rating: 46/100 against 17/100
- headcount: 67 against 9
- funding raised: $22.0M against $5.2M
- LinkedIn following: 131,499 against 3,138
At a glance
| Measure | PFx Biotech | Triomics |
|---|---|---|
| What it is | PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics. | Advance every cancer decision. |
| Category | Biotech, Drug Discovery, Genomics, AI-Driven Protein Design | Biotech, HealthTech, Drug Discovery, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2021 |
| Headquarters | Cambridge, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | PFx Biotech | Triomics |
|---|---|---|
| Employees | 9 | 67 |
| Total funding | $5.2M | $22.0M |
| Latest round | Not published | Series B |
| LinkedIn followers | 3,138 | 131,499 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | PFx Biotech | Triomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 53/100 |
| Traction | 44/100 | 55/100 |
| Team | 60/100 | Not published |
| Search visibility | 29/100 | 33/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 17/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | PFx Biotech | Triomics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Not detected | Webflow |
| Open source | Yes | No |
PFx Biotech vs Triomics: common questions
Which is better, PFx Biotech or Triomics?
On our 0-100 score Triomics rates higher (53/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do PFx Biotech and Triomics compare on the numbers?
PFx Biotech leads on agent readiness (44/100 against 30/100). Triomics leads on domain rating (46/100 against 17/100), headcount (67 against 9), funding raised ($22.0M against $5.2M), LinkedIn following (131,499 against 3,138).
Read the full PFx Biotech review and pricing or the Triomics review and pricing. You can also browse other PFx Biotech alternatives we track.